Regulatory decisions utilising MLA data Pre clinical safety evaluation for potential carcinogens Identification of mutagens (mutation is the endpoint of concern) Support for hazard identification (weight of the evidence to address question - is chemical a mutagen or carcinogen ) Use for hazard assessment/Mode of Action and Risk Assessment Classification and Labelling
{}